CD22 is an inhibitory co-receptor of the B-cell receptor that is expressed on the surface of normal B lymphocytes and also many malignant B cells including chronic B-lymphocytic cells (B-CLL), B-lymphoma cells such as Burkitt’s lymphoma, and hairy cell leukemia (HCL). Here, CD22 is linked to Burkitt lymphoma.